Followers | 241 |
Posts | 16027 |
Boards Moderated | 1 |
Alias Born | 09/16/2005 |
Wednesday, August 17, 2016 9:35:06 PM
Recent KURA News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:15:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:10:09 PM
- Kura Oncology Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/08/2024 08:05:00 PM
- Kura Oncology Announces FDA Clearance of IND Application for Menin Inhibitor Ziftomenib in Advanced Gastrointestinal Stromal Tumors (GIST) • GlobeNewswire Inc. • 08/08/2024 11:30:00 AM
- Kura Oncology to Report Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
- Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/05/2024 11:30:00 AM
- Kura Oncology Reports Preclinical Data Supporting Potential for Menin Inhibitor in Diabetes • GlobeNewswire Inc. • 06/24/2024 11:30:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/07/2024 08:30:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:30:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:30:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:05:11 PM
- Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/07/2024 11:30:00 AM
- Kura Oncology to Participate in Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/29/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:06:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 10:30:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/20/2024 08:19:43 PM
- Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Kura Oncology to Participate in Bank of America Securities Healthcare Conference • GlobeNewswire Inc. • 05/08/2024 11:30:00 AM
- Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/03/2024 11:30:00 AM
- Kura Oncology Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/02/2024 08:05:00 PM
- Kura Oncology to Report First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/25/2024 11:30:00 AM
- Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML • GlobeNewswire Inc. • 04/22/2024 11:30:00 AM
- Kura Oncology to Participate in Stifel Targeted Oncology Forum • GlobeNewswire Inc. • 04/10/2024 11:30:00 AM
- Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/05/2024 11:30:00 AM
- Kura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib in Renal Cell Carcinoma • GlobeNewswire Inc. • 03/06/2024 12:30:00 PM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM